BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33495318)

  • 21. NMDA and AMPA/kainate glutamatergic agonists increase the extracellular concentrations of GABA in the prefrontal cortex of the freely moving rat: modulation by endogenous dopamine.
    Del Arco A; Mora F
    Brain Res Bull; 2002 Mar; 57(5):623-30. PubMed ID: 11927365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical and raphe GABA
    Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
    Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.
    Inserra A; De Gregorio D; Rezai T; Lopez-Canul MG; Comai S; Gobbi G
    J Psychopharmacol; 2021 Apr; 35(4):469-482. PubMed ID: 33645311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats.
    Popik P; Krawczyk M; Kuziak A; Bugno R; Hogendorf A; Staroń J; Nikiforuk A
    J Psychopharmacol; 2019 Nov; 33(11):1447-1455. PubMed ID: 31452444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling.
    Inserra A; Campanale A; Cheishvili D; Dymov S; Wong A; Marcal N; Syme RA; Taylor L; De Gregorio D; Kennedy TE; Szyf M; Gobbi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110594. PubMed ID: 35777526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
    Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
    Björkholm C; Frånberg O; Malmerfelt A; Marcus MM; Konradsson-Geuken Å; Schilström B; Jardemark K; Svensson TH
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
    Voleti B; Navarria A; Liu RJ; Banasr M; Li N; Terwilliger R; Sanacora G; Eid T; Aghajanian G; Duman RS
    Biol Psychiatry; 2013 Nov; 74(10):742-9. PubMed ID: 23751205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained Activation of Postsynaptic 5-HT2A Receptors Gates Plasticity at Prefrontal Cortex Synapses.
    Berthoux C; Barre A; Bockaert J; Marin P; Bécamel C
    Cereb Cortex; 2019 Apr; 29(4):1659-1669. PubMed ID: 29917056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist.
    Gordillo-Salas M; Pilar-Cuéllar F; Auberson YP; Adell A
    Transl Psychiatry; 2018 Apr; 8(1):84. PubMed ID: 29666360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxytocin Exerts Antidepressant-like effect by potentiating dopaminergic synaptic transmission in the mPFC.
    Li Q; Zhang B; Cao H; Liu W; Guo F; Shen F; Ye B; Liu H; Li Y; Liu Z
    Neuropharmacology; 2020 Jan; 162():107836. PubMed ID: 31682854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tsc1 haploinsufficiency in Nkx2.1 cells upregulates hippocampal interneuron mTORC1 activity, impairs pyramidal cell synaptic inhibition, and alters contextual fear discrimination and spatial working memory in mice.
    Haji N; Riebe I; Aguilar-Valles A; Artinian J; Laplante I; Lacaille JC
    Mol Autism; 2020 May; 11(1):29. PubMed ID: 32375878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar-Kyoto rats.
    Papp M; Gruca P; Lason M; Litwa E; Solecki W; Willner P
    J Psychopharmacol; 2020 Dec; 34(12):1418-1430. PubMed ID: 33200659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat.
    Björkholm C; Jardemark K; Schilström B; Svensson TH
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1842-7. PubMed ID: 26233606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
    Arvanov VL; Wang RY
    Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Akt-independent mTORC1 and GSK3β signaling in sublethal NMDA-induced injury and the recovery of neuronal electrophysiology and survival.
    Swiatkowski P; Nikolaeva I; Kumar G; Zucco A; Akum BF; Patel MV; D'Arcangelo G; Firestein BL
    Sci Rep; 2017 May; 7(1):1539. PubMed ID: 28484273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
    Gresch PJ; Strickland LV; Sanders-Bush E
    Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.